文献速递瓣膜病与结构性心脏病

经桡动脉微创球囊主动脉瓣成形术的安全性、疗效及对衰弱的影响

Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty.
PubMed 文献 · Heart · 2021-02-24

该前瞻性多中心研究纳入330例在意大利16个中心接受球囊主动脉瓣成形术(BAV)的患者,其中95%经桡动脉入路。结果显示VARC-2大出血为零、小出血仅1.8%,生活质量和衰弱状态在30天后显著改善;BAV后30天达到EFT<3的患者后续TAVI预后较好,而EFT≥3者全因死亡风险最高。

要点

  • 经桡动脉微创BAV安全可行,VARC-2大出血为零、小出血1.8%。
  • BAV后30天生活质量和衰弱状态(EFT)显著改善。
  • BAV后30天EFT≥3者TAVI后全因死亡风险最高(40%)。

核心结论

  • 经桡动脉微创BAV安全可行且血管并发症发生率低。
  • BAV后30天EFT改善的患者在后续TAVI中预后良好。

研究设计与样本

  • 前瞻性研究,纳入在意大利16个中心接受BAV的330例患者。
  • 主要终点为VARC-2大出血和小出血的发生。
  • 次要终点包括基线和30天时评估的生活质量与衰弱量表及其与全因死亡的关系。

主要发现

  • 314例(95%)患者经桡动脉完成BAV。
  • 研究人群无VARC-2大出血,发生6例(1.8%)VARC-2小出血。
  • BAV后30天生活质量和衰弱状态显著改善。
  • 1年时,基线EFT<3或BAV后达到EFT<3并接受TAVI的患者全因死亡发生率相当(15% vs 19%,p=0.58)。
  • BAV后30天EFT仍≥3的患者预后最差(全因死亡:40% vs 15%和19%,p=0.006和p=0.05)。

关键数值与推荐

  • 主要终点为VARC-2大出血和小出血。
  • 衰弱评估采用EFT(essential frailty toolset),阈值3分。

临床怎么用

  • 经桡动脉微创BAV可作为TAVI前改善衰弱状态的过渡策略。
  • BAV后30天应重新评估EFT,EFT≥3提示后续TAVI预后不佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study was designed to: (1) confirm safety and feasibility of mini-invasive radial balloon aortic valvuloplasty (BAV); (2) assess its impact in terms of quality of life and frailty; and (3) evaluate whether changes in frailty after BAV are associated with death in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS: 330 patients undergoing BAV in 16 Italian centres were prospectively included. The primary endpoint was the occurrence of major and minor Valve Academic Research Consortium (VARC)-2 bleeding. Secondary endpoints were scales of quality of life, frailty, evaluated at baseline and 30 days, and their relationship with the occurrence of all-cause death. RESULTS: BAV was performed by radial access in 314 (95%) patients. No VARC-2 major and six (1.8%) VARC-2 minor bleedings occurred in the study population. Quality of life, as well as frailty status, significantly improved 30 days after BAV. At 1 year, patients undergoing TAVI with baseline essential frailty toolset (EFT) <3 or achieving an EFT <3 after BAV had a comparable occurrence of all-cause death (15% vs 19%, p=0.58). On the contrary, patients with EFT ≥3 at 30 days despite BAV showed the worst prognosis (all-cause death: 40% vs 15% and 19%, p=0.006 and p=0.05, respectively). CONCLUSIONS: Mini-invasive radial BAV is safe, feasible and associated with a low rate of vascular complications. Patients improving EFT 30 days after BAV showed a favourable outcome after TAVI. TRIAL REGISTRATION NUMBER: NCT03087552.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Tumscitz C, Di Cesare A, Balducelli M, et al. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty. Heart. 2021. PMID: 33627400. doi:10.1136/heartjnl-2020-318548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。